| Methodist Orthotics & Prosthetics | |
| 1 Layfair Dr, Ste 300, Flowood, Mississippi 39232 | |
| (601) 936-8899 |
| Name | Methodist Orthotics & Prosthetics |
|---|---|
| Organization Name | Mississippi Methodist Hospital & Rehabilitation Center Inc |
| Location | 1 Layfair Dr, Ste 300, Flowood, Mississippi 39232 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (601) 936-8899 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Millions of children with epilepsy in developing countries are being denied an effective drug that costs less than $3 a year, according to an editorial in the British Medical Journal.
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Researchers report that they have found a potential molecular cause for the aggressive growth and spread of human head and neck squamous cell carcinoma, a highly malignant form of cancer with a very high death rate.
When President Donald Trump demands a border wall or threatens to deport young unauthorized immigrants, one of the loudest opposition voices comes from the son of Mexican immigrants — who also happens to be California's top lawyer.
› Verified 8 days ago
| NPI Number | 1770621963 |
| Organization Name | MISSISSIPPI METHODIST HOSPITAL & REHABILITATION CENTER, INC. |
| Doing Business As | METHODIST REHAB CENTER |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1 Layfair Dr Ste 300, Flowood, MS 39232 |
| Phone Number | 601-936-8899 |
News Archive
Millions of children with epilepsy in developing countries are being denied an effective drug that costs less than $3 a year, according to an editorial in the British Medical Journal.
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Researchers report that they have found a potential molecular cause for the aggressive growth and spread of human head and neck squamous cell carcinoma, a highly malignant form of cancer with a very high death rate.
When President Donald Trump demands a border wall or threatens to deport young unauthorized immigrants, one of the loudest opposition voices comes from the son of Mexican immigrants — who also happens to be California's top lawyer.
› Verified 8 days ago
| NPI Number | 1790265627 |
| Organization Name | MISSISSIPPI BRAIN AND SPINE, PLLC |
| Doing Business As | MS BRAIN AND SPINE |
| Type | Non-Pharmacy Dispensing Site |
| Address | 1 Layfair Drive, Ste 120, Flowood, MS 39232 |
| Phone Number | 888-590-0808 |
News Archive
Millions of children with epilepsy in developing countries are being denied an effective drug that costs less than $3 a year, according to an editorial in the British Medical Journal.
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Researchers report that they have found a potential molecular cause for the aggressive growth and spread of human head and neck squamous cell carcinoma, a highly malignant form of cancer with a very high death rate.
When President Donald Trump demands a border wall or threatens to deport young unauthorized immigrants, one of the loudest opposition voices comes from the son of Mexican immigrants — who also happens to be California's top lawyer.
› Verified 8 days ago
News Archive
Millions of children with epilepsy in developing countries are being denied an effective drug that costs less than $3 a year, according to an editorial in the British Medical Journal.
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Researchers report that they have found a potential molecular cause for the aggressive growth and spread of human head and neck squamous cell carcinoma, a highly malignant form of cancer with a very high death rate.
When President Donald Trump demands a border wall or threatens to deport young unauthorized immigrants, one of the loudest opposition voices comes from the son of Mexican immigrants — who also happens to be California's top lawyer.
› Verified 8 days ago
Mobility Medical, Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 554 Park Lane, Flowood, Mississippi 39232 Phone: (601) 932-1001 | |
Amber Specialty Pharmacy Type: Medicare Supplier Location: 3010 Lakeland Cv, Flowood, Mississippi 39232 Phone: (888) 370-1724 | |
Cvs Pharmacy #08311 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4899 Lakeland Dr, Flowood, Mississippi 39232 Phone: (601) 919-3044 | |
Cvs Pharmacy #17038 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 170 Promenade Blvd, Flowood, Mississippi 39232 Phone: (601) 992-0676 | |
Walmart Pharmacy 10-2755 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5341 Lakeland Dr, Flowood, Mississippi 39232 Phone: (601) 992-8144 |